pharma

Dendreon: The FDA's Commissioner Doth Protest Too Much!

FDA oncology division is a total disgrace. It chief Dr. Pazdur has done everything in his power to kill cancer drug Erbitux which with huge time delay has been approved in colorectal and head & neck cancer applications as well as on its way to be approved in lung and other cancers. This year, ASCO 2008, the most prestigious international oncology conference, will feature Erbitux as a drug that is changing oncology paradigm. The drug not only prolongs lives of cancer patients and improves their quality of life but also cures good many of cancer patients.

Dr. Pazdur was very instrumental in FDA decision even to deny Erbitux consideration for an approval. He leaked confidential FDA information [he himself admitted it at the congressional hearing].

The Provenge saga is very much similar to Erbitux's FDA adventure. IMO, FDA oncology group is directly responsible for endless cancer patients suffering and deaths.